This inventor holds 1 USPTO granted patent. Top assignee: Upm-Kymmene Corporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jukka Rissanen: Innovator in Injectable Pharmaceutical Formulations
Introduction
Jukka Rissanen is a notable inventor based in Kuusisto, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. His work focuses on enhancing the delivery and efficacy of pharmaceutical compounds through advanced materials.
Latest Patents
Rissanen holds a patent for an injectable pharmaceutical formulation. This formulation includes nanofibrillar cellulose hydrogel, with the content of nanofibrillar cellulose ranging from 1-8% (w/w). The formulation is designed to provide a sustained release of a pharmaceutical compound in a subject. Additionally, the use of nanofibrillar cellulose for preparing this injectable pharmaceutical formulation is disclosed in his patent.
Career Highlights
Jukka Rissanen is associated with UPM-Kymmene Corporation, a leading company in the forest industry. His role at the company allows him to leverage his expertise in material science and pharmaceuticals to develop innovative solutions. His work has the potential to impact the pharmaceutical industry significantly.
Collaborations
Rissanen collaborates with talented individuals such as Markus Nuopponen and Lauri Paasonen. These collaborations enhance the research and development efforts within his field, fostering innovation and progress.
Conclusion
Jukka Rissanen is a prominent inventor whose work in injectable pharmaceutical formulations showcases his commitment to advancing medical science. His innovative approach and collaboration with skilled professionals contribute to the ongoing evolution of pharmaceutical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
